Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)
The Tape - Podcast autorstwa Bloomberg Radio
Kategorie:
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.
